Written by Tamr
Tamr was approached by a multinational biopharmaceutical company to transform the process of preparing its clinical data for analytics. The organization wanted to analyze the trove of unmined clinical trial and biomarker data in order to more effectively guide translational research and drug development. In doing so, the company sought to empower translational scientists with analytic-ready data across both new and historical clinical trials.
Download the full case study here.